Skip to main content
NCBI home page
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2022 Jul 30;2022:1949159. doi: 10.1155/2022/1949159

Correlation Analysis of miR-1246 Expression in Saliva of Patients with Chronic Periodontitis and Periodontal Indexes, Inflammatory Cytokines, and Protease Molecules

Shuainan Wu 1,✉, Zhaobao Li 1, Jianqi Wang 1, Lu Liu 1, Ying Pang 1
PMCID: PMC9356776  PMID: 35942384

Abstract

Objective

The study aimed to investigate the correlation of miR-1246 in saliva with periodontal indicators, inflammatory cytokines, and protease molecules in patients with chronic periodontitis.

Methods

Thirty-five patients with chronic periodontitis were included as the chronic periodontitis group, and 35 healthy individuals were selected as the healthy control group during the same period. The miR-1246 levels, inflammatory cytokine interleukin (IL)-1β, IL-6, IL-17, tumor necrosis factor-α (TNF-α), matrix metalloproteinase (MMP-1), MMP-8, and MMP tissue inhibitor (TIMP-1) in saliva were determined, and periodontal indexes, including the plaque index (PLI), bleeding index (BI), periodontal probing depth (PD), and attachment loss (AL) were examined.

Results

The salivary levels of miR-1246, IL-1β, IL-6, IL-17, TNF-α, MMP-1, MMP-8, and TIMP-1 and the periodontal indexes PLI, GI, PD, and AL in the chronic periodontitis group were significantly higher than those in the healthy control (P < 0.05). Salivary levels of miR-1246 in patients with chronic periodontitis were positively correlated with the levels of IL-1β, IL-6, IL-17, TNF-α, MMP-1, MMP-8, TIMP-1, PLI, GI, PD, and AL (P < 0.05).

Conclusion

Abnormally elevated levels of miR-1246 in saliva of patients with chronic periodontitis correlate with levels of periodontal indices, inflammatory cytokines, and protease molecules.

1. Introduction

Chronic periodontitis is a chronic infectious disease of the gingiva and periodontal tissue caused by periodontal pathogens such as Porphyromonas gingivalis and Plasmodium intermedium. It can trigger host immune defense and inflammatory responses, leading to massive production of cytokines [1]. Inflammatory factors such as tumor necrosis factor-α (TNF-α), interleukin-1β interleukin (IL)-1β, IL-6, and IL-17 play an important role in the pathology of chronic periodontitis because they cause secondary damage to periodontal tissues thereby exacerbating the destruction of periodontal tissues [2]. It has been reported that TNF-α, IL-1β, IL-6, and IL-17 are highly expressed in periodontal tissues such as periodontal membranes of patients with chronic periodontitis as the expression level increases with the increase of inflammation [3]. MicroRNAs (miRNAs) are newly discovered endogenous nonprotein-coding single-stranded RNAs consisting of 21–24 nucleotides that regulate protein expression by degrading miRNAs or inhibiting their translation through complementary pairing with target gene mRNAs [4]. They are widely involved in the development of various diseases such as infectious diseases, immune diseases, cardiovascular diseases, and viral infections; i.e., changes in microRNA expression levels may indicate the presence of a disease [5].

The expression profiles of miRNAs in saliva are similar to those in tissues and plasma, and significant changes in specific miRNAs have been observed in saliva, diseased tissues, and blood [6]. There is increasing evidence that aberrant miRNA expression is closely associated with the pathogenesis of chronic inflammation. Thus, miRNAs in saliva show great potential as diagnostic and therapeutic targets for diseases. A recent study [7] revealed an important role of changes in miRNA expression levels, especially miR-1246, in the development of inflammation. However, changes in miR-1246 in chronic periodontitis in China and their significance have been rarely reported. Therefore, this study analyzed the correlation between miR-1246 levels in saliva of patients with chronic periodontitis and the levels of periodontal indicators, inflammatory cytokines, and protease-related molecules to elucidate the role of miR-1246 in the development of chronic periodontitis, as well as to provide a basis for exploring the pathogenesis of chronic periodontitis and finding new targets for future diagnosis and treatment.

2. Materials and Methods

2.1. General Data

Thirty-five patients with chronic periodontitis treated in our hospital from September 2020 to June 2021 were selected as the chronic periodontitis group, including 25 males and 10 females, aged 31 ∼ 67 years. Another 35 cases of healthy individuals under physical examination in our hospital during the same period were selected as the control group, including 23 males and 12 females, aged 32 ∼ 69 years. All patients met the diagnostic criteria for chronic periodontitis developed by the International Symposium on Periodontal Classification in 1999.

Inclusion criteria were as follows [8]: ① patients without oral or local inflammation, including tonsillitis and pharyngitis; ② patients without immune diseases, infectious diseases, or other systemic diseases; ③ patients without antibiotics or periodontal basic treatment in the last 3 months; ④ no pregnant or lactating women.

2.2. Apparatus and Reagents

The miRNA extraction kit, miRNA c DNA first-strand synthesis kit, miRNA fluorescence quantitative polymerase chain reaction (PCR) assay kit, IL-1β, IL-6, IL-17, tumor necrosis factor-α (TNF-α), and matrix metalloproteinase (MMP)-1, MMP-8, and MMP tissue inhibitory factor-1 (TIMP-1) ELISA kits were purchased from Beijing Convoy Century, Inc.

3. Methods

3.1. Determination of Periodontal Indexes

All subjects received an oral examination completed by the same physician, and the periodontal probing depth (PD) and clinical attachment loss (AL) were detected with the William periodontal probe; the plaque index (PLI) and the bleeding index (BI) were recorded.

3.2. Collection of Saliva Specimens

Samples were collected before treatment in the chronic periodontitis group and during physical examination in the healthy control group. In the morning, the mouth was wiped with a cotton swab dipped in 2% citric acid to collect about 1 ml of saliva in a 1.5 ml electrophysiology tube, followed by centrifugation at 3000 rpm for 15 min at 4°C to obtain the supernatant. The supernatant was divided into two portions and stored at −80°C.

3.3. Determination of miR-1246 Levels in Saliva

One portion of the supernatant was used for the determination of miR-1246 levels. The real-time fluorescence quantitative PCR was performed on an ABI 7500 fluorescence quantitative PCR instrument. The total PCR reaction system was 20 μl: primer and probe 1 μl mix (20×), TaqMan universal mix 10 μl (2×), reverse transcription product cDNA 1.33 μl, and nuclease-free water 7.67 μl. The amplification conditions were as follows: 95°C for 10 min 1 cycle, 95°C for 15 s, and 60°C for 60 s 45 cycles. The number of cycles in each reaction system where the fluorescence signal reached the set threshold was the Ct value, and the expression level of miR-1246 was calculated using the 2−△△Ct method. The delta-delta Ct method, also known as the 2−△△Ct method, is a simple formula used to calculate the relative fold gene expression of a sample when performing real-time polymerase chain reaction (also known as qPCR). This method was devised in 2001 by Kenneth Livak and Thomas Schmittgen [9].

3.4. Determination of Inflammatory Cytokines and Protease-Related Molecules in Saliva

Another saliva sample was used for the determination of the levels of IL-1β, IL-6, IL-17, TNF-α, MMP-1, MMP-8, and TIMP-1 using the ELISA, and all assays were performed according to the kit's instructions.

3.5. Severity Grading of Periodontitis

Gingival inflammation and bleeding on probing, periodontal pocket depth ≤4 mm, radiographs showing alveolar bone resorption not exceeding 1/3 of the root length, and bad breath were considered mild according to severity grading. Gingival inflammation and bleeding on probing, also pus may be present, periodontal pocket depth ≤6 mm, X-ray showing alveolar bone resorption more than 1/3 of the root length but not more than 1/2 of the root length, and the teeth having mild loosening were considered moderate according to severity grading. More pronounced inflammation or periodontal abscess, periodontal pocket >6 mm, X-ray showing alveolar bone resorption more than 1/2 of the root length, and the tooth being mostly loose were considered severe according to severity grading [10, 11].

3.6. Statistical Analyses

SPSS 23.0 software was used for data processing and statistical analysis. The measurement data were all continuous variables conforming to the normal distribution, expressed as the mean ± standard error, and the t-test was used for comparison between groups. The count data were expressed as percentages, and the chi-square test was used for comparison between groups. Pearson correlation was used to analyze the correlation between the indicators. A difference was considered statistically significant at P < 0.05.

4. Results

4.1. Comparison of General Data

There was no statistically significant difference between the two groups of patients in terms of general data such as age and gender (P < 0.05) (see Table 1).

Table 1.

Comparison of general data between the two groups.

Groups n Gender Age (year) Hypertension Smoking Drinking
Male Female
Health control group 35 25 10 57.87 ± 9.26 13 16 13
Chronic periodontitis group 35 23 12 57.42 ± 7.75 17 19 15
χ 2 /t   0.032   0.824 0.142 0.342 0.216
P   0.825   0.126 0.726 0.861 0.798
Open in a new tab

4.2. Comparison of miR-1246 Levels

The miR-1246 level of the chronic periodontitis group was 2.13 ± 0.41, which was significantly higher than that of 0.92 ± 0.11 in the healthy control group (P < 0.05) (see Table 2).

Table 2.

Comparison of miR-1246 levels between the two groups.

Groups n miR-1246 level t P
Health control group 35 0.92 ± 0.11 14.367 ≤0.001
Chronic periodontitis group 35 2.13 ± 0.41    
Open in a new tab

4.3. Comparison of Periodontal Indexes

Compared with the healthy control group, the chronic periodontitis group had significantly higher levels of PLI, BI, PD, and AL (P < 0.05), as shown in Table 3.

Table 3.

Comparison of periodontal indexes between the two groups.

Groups n PLI BI PD (mm) AL (mm)
Health control group 35 0.89 ± 0.12 1.09 ± 0.22 1.82 ± 0.47 0.73 ± 0.15
Chronic periodontitis group 35 3.13 ± 0.51 3.47 ± 0.79 6.61 ± 0.88 7.65 ± 1.17
t   22.872 18.472 29.026 39.461
P   ≤0.001 ≤0.001 ≤0.001 ≤0.001
Open in a new tab

4.4. Comparison of Salivary Levels of Inflammatory Cytokines

Significantly higher levels of IL-1β, IL-6, IL-17, and TNF-α were found in saliva of the chronic periodontitis group compared with the healthy control group (P < 0.05), as shown in Table 4.

Table 4.

Comparison of salivary levels of inflammatory cytokines between the two groups.

Groups n IL-1β (pg/ML) IL-6 (pg/ML) IL-17 (pg/ML) TNF-α (pg/ML)
Health control group 35 1.89 ± 0.37 3.01 ± 0.59 7.64 ± 0.91 0.93 ± 0.12
Chronic periodontitis group 35 3.45 ± 0.63 5.76 ± 0.82 12.52 ± 3.01 2.38 ± 0.51
t   12.753 16.842 10.486 16.771
P   ≤0.001 ≤0.001 ≤0.001 ≤0.001
Open in a new tab

4.5. Comparison of Protease-Related Molecule Levels in Saliva

The levels of MMP-1, MMP-8, and TIMP-1 in saliva were markedly higher in the chronic periodontitis group than those in the healthy control group (P < 0.05), as shown in Table 5.

Table 5.

Comparison of protease-related molecule levels in saliva of the two groups.

Groups n MMP-1 MMP-8 TIMP-1
Health control group 35 1.68 ± 0.31 12.41 ± 2.45 3.08 ± 0.59
Chronic periodontitis group 35 3.82 ± 0.79 33.07 ± 7.13 4.18 ± 0.82
t   15.862 18.371 7.307
P   ≤0.001 ≤0.001 ≤0.001
Open in a new tab

4.6. Correlation of miR-1246 Levels with Inflammatory Cytokines and Protease Molecules in Saliva of Patients with Chronic Periodontitis

Salivary levels of miR-1246 in patients with chronic periodontitis were positively correlated with the levels of IL-1β, IL-6, IL-17, TNF-α, MMP-1, MMP-8, and TIMP-1 (P < 0.05), as shown in figures 1–7.

Figure 1.

Figure 1

Open in a new tab

Positive correlation between miR-124 and IL-1β.

Figure 2.

Figure 2

Open in a new tab

Positive correlation between miR-124 and IL-6.

Figure 3.

Figure 3

Open in a new tab

Positive correlation between miR-124 and IL-7.

Figure 4.

Figure 4

Open in a new tab

Positive correlation between miR-124 and TNF-α.

Figure 5.

Figure 5

Open in a new tab

Positive correlation between miR-124 and MMP-1.

Figure 6.

Figure 6

Open in a new tab

Positive correlation between miR-124 and MMP-8.

Figure 7.

Figure 7

Open in a new tab

Positive correlation between miR-124 and TIMP-1.

5. Discussion

Chronic periodontitis is an inflammatory and destructive disease of periodontal supporting tissues, characterized by alveolar bone resorption and gingival recession and has become a common chronic disease that endangers human oral health [12]. It is a chronic or acute recurrent progressive inflammatory disease caused by plaque, and its products act on periodontal tissues and activate the host's inflammatory immune response [13]. The inflammation they cause extends to deeper tissues and leads to the destruction of periodontal tissues [14]. Any factor that can aggravate plaque retention, such as tartar, poor restorations, food impaction (plugged teeth), misalignment of teeth, and abnormal anatomical morphology, can become a local promoter of periodontitis, aggravating and accelerating its progression [15]. Periodontitis is a multifactorial disease, and certain systemic diseases such as diabetes mellitus can also negatively affect periodontitis [16]. No systemic disease or dysfunction is thought to directly contribute to the development of chronic periodontitis [17]. In addition, certain environmental and behavioral factors such as smoking and mental stress may be risk factors. In recent years, it has been found that genetic background may also be associated with chronic periodontitis [18].

miRNA, as an endogenous noncoding small molecule, is involved in the regulation of post-transcriptional gene expression and plays a role in the pathogenesis of periodontitis [19]. Previous studies have found that aberrant miR-1246 expression in inflammatory diseases could show great potential as an important biomarker for monitoring inflammatory disease status because miR-1246 is involved in inflammatory factor signaling and regulation of immune cell differentiation and immune function [20]. In recent years, the role of host inflammatory immune response in periodontal disease progression has been well studied and recognized. Periodontal cell populations are heterogeneous multifunctional cell populations containing stem cells, fibroblasts, osteoblasts, dentin-forming osteoclasts, Malassezia epithelial remnants, immune cells, undifferentiated mesenchymal cells, and dentin-forming cell vesicles [21]. During inflammatory episodes, host immune cells fight pathogenic microorganisms, kill bacteria, and participate in the immune response [22]. miR-1246 regulates the activation of monocytes, macrophages, and neutrophils in T-cell-mediated and B-cell-mediated immune responses [23]. Adeodato et al. (2020) found in a miR-1246 knockout mouse hair growth center model that B-cell production with a corresponding decrease in interleukin 2 and interferon γ production have loss of the ability to produce high-affinity IgG1 antibodies, TNF-α, and lymphotoxin [24].

Activation of the inflammatory response in plaque-stimulated periodontal tissues is the underlying pathological change in chronic periodontitis, and periodontal tissues release large amounts of inflammatory factors such as IL-1β, IL-6, IL-17, and TNF-α [25]. The elevated levels of these inflammatory cytokines in the gingival sulcus fluid of patients with periodontitis have been demonstrated, and the results of the analysis in the present study are consistent with previous studies [26]. Furthermore, in the present study, the levels of miR-1246 in saliva of patients with chronic periodontitis were positively correlated with the levels of IL-1β, IL-6, IL-17, and TNF-α, indicating a correlation between the two. With the release of inflammatory factors and activation of the inflammatory response, miR-1246 levels increased. Activation of the inflammatory response in periodontal tissues can lead to local infiltration of multiple inflammatory cells, release of proteases, and inhibitory molecules such as MMP-1, MMP-8, and TIMP-1 that mediate periodontal tissue hydrolysis and destruction [10, 27]. The results of this study also showed a positive correlation between MMP-1, MMP-8, TIMP-1 levels, and miR-1246 levels in the chronic periodontitis group, suggesting that increased miR-1246 expression may be associated with the destruction of periodontal tissues by proteases in chronic periodontitis.

Imaging evaluation can provide information about the severity of periodontitis based on its findings of probing depth, attachment level, bleeding detection, and alveolar bone loss but is relatively expensive and unable to detect disease activity [28, 29]. Many herbs are very effective in preventing chronic diseases, and herbs can be effective in the prevention, treatment, or prognosis of chronic periodontitis [30, 31]. In Chinese medicine, the identification of periodontitis is mainly related to the dysfunction of the internal organs, with the incandescence of stomach heat and deficiency of kidney qi being the most common [32]. However, when periodontitis occurs, it cannot be cured radically if it is treated only by TCM, so a combination of western medicine is also needed [33]. In clinical practice, gingivitis can gradually and insidiously transition into periodontitis, so early detection and diagnosis of periodontitis are important because the consequences of periodontitis are far more serious than gingivitis [34, 35]. Therefore, it is important to find efficient diagnostic indicators and new therapeutic targets, which is the significance of the study we conducted.

6. Conclusion

In conclusion, abnormally elevated levels of miR-1246 in saliva of patients with chronic periodontitis correlate with levels of periodontal indices, inflammatory cytokines, and protease molecules, which indicate their involvement in the development of chronic periodontitis. However, due to the small sample size and the short follow-up period, future studies with expanded samples and longer follow-up periods are required.

Abbreviations

(PLI):

Plaque index

(BI):

Bleeding index

(PD):

Periodontal probing depth

(AL):

Attachment loss

(PCR):

Polymerase chain reaction.

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Ethical Approval

This experiment conformed to the Ethics Committee of Cangzhou Central Hospital, and all the methods were carried out in accordance with the Declaration of Helsinki.

Consent

The informed consent forms were obtained from the patients.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

SN W performed the majority of experiments; ZBL and Y P analyzed the data; JQ W drew charts; LL designed and coordinated the research; SN W wrote the paper. All authors reviewed the manuscript. All authors have read and approved the manuscript.

References

  • 1.Wadhawan A., Reynolds M. A., Makkar H. Periodontal pathogens and neuropsychiatric health. Current Topics in Medicinal Chemistry . 2020;20(15):1353–1397. doi: 10.2174/1568026620666200110161105. [DOI] [PubMed] [Google Scholar]
  • 2.Emfietzoglou R., Pachymanolis E., Piperi C. Impact of epigenetic alterations in the development of oral diseases. Current Medicinal Chemistry . 2021;28(6):1091–1103. doi: 10.2174/0929867327666200114114802. [DOI] [PubMed] [Google Scholar]
  • 3.Cuevas-González M. V., Suaste-Olmos F., García-Calderón A. G. Expression of MicroRNAs in periodontal disease: a systematic review. BioMed Research International . 2021;2021 doi: 10.1155/2021/2069410.2069410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Luo Y., Peng X., Duan D., Liu C., Xu X., Zhou X. Epigenetic regulations in the pathogenesis of periodontitis. Current Stem Cell Research and Therapy . 2018;13(2):144–150. doi: 10.2174/1574888x12666170718161740. [DOI] [PubMed] [Google Scholar]
  • 5.Wen J. H., Wu Y. M., Chen L. L. [Functions of non-coding RNAs in the osteogenic differentiation of human periodontal ligament-derived cells] Hua xi kou qiang yi xue za zhi . 2020;38(3):330–337. doi: 10.7518/hxkq.2020.03.018. in Chinese. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Luan X., Zhou X., Naqvi A. MicroRNAs and immunity in periodontal health and disease. International Journal of Oral Science . 2018;10(3):p. 24. doi: 10.1038/s41368-018-0025-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Asa’ad F., Garaicoa-Pazmiño C., Dahlin C. Expression of MicroRNAs in periodontal and peri-implant diseases: a systematic review and meta-analysis. International Journal of Molecular Sciences . 2020;21(11):p. 4147. doi: 10.3390/ijms21114147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Momen-Heravi F., Bala S. miRNA regulation of innate immunity. Journal of Leukocyte Biology . 2018;103(6):1205–1217. doi: 10.1002/JLB.3MIR1117-459R. [DOI] [PubMed] [Google Scholar]
  • 9.Rao X., Huang X., Zhou Z., Lin X. An improvement of the 2ˆ (–delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, bioinformatics and biomathematics . 2013;3(3):71–85. [PMC free article] [PubMed] [Google Scholar]
  • 10.Tonetti M. S., Greenwell H., Kornman K. S. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. Journal of Periodontology . 2018;89(Suppl 1):S159–S172. doi: 10.1002/JPER.18-0006. [DOI] [PubMed] [Google Scholar]
  • 11.Ravidà A., Rodriguez M. V., Saleh M. H. A., et al. The correlation between history of periodontitis according to staging and grading and the prevalence/severity of peri-implantitis in patients enrolled in maintenance therapy. Journal of Periodontology . 2021;92(11):1522–1535. doi: 10.1002/jper.21-0012. [DOI] [PubMed] [Google Scholar]
  • 12.Wadhawan A., Reynolds M. A., Makkar H., et al. Periodontal pathogens and neuropsychiatric health. Current Topics in Medicinal Chemistry . 2020;20(15):1353–1397. doi: 10.2174/1568026620666200110161105. [DOI] [PubMed] [Google Scholar]
  • 13.Self-Fordham J. B., Naqvi A. R., Uttamani J. R. MicroRNA: dynamic regulators of macrophage polarization and plasticity. Frontiers in Immunology . 2017;8:p. 1062. doi: 10.3389/fimmu.2017.01062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Könönen E., Gursoy M., Gursoy U. K. Periodontitis: a multifaceted disease of tooth-supporting tissues. Journal of Clinical Medicine . 2019;8(8):p. 1135. doi: 10.3390/jcm8081135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ratcliff P. A., Johnson P. W. The relationship between oral malodor, gingivitis, and periodontitis. A review. Journal of Periodontology . 1999;70(5):485–489. doi: 10.1902/jop.1999.70.5.485. [DOI] [PubMed] [Google Scholar]
  • 16.Lim G., Janu U., Chiou L. L., Gandhi K. K., Palomo L., John V. Periodontal health and systemic conditions. Dentistry Journal . 2020;8(4):p. 130. doi: 10.3390/dj8040130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cullinan M. P., Seymour G. J. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontology . 2013;62(1):271–286. doi: 10.1111/prd.12007. [DOI] [PubMed] [Google Scholar]
  • 18.Nazir M. A. Prevalence of periodontal disease, its association with systemic diseases and prevention. International Journal of Health Sciences . 2017;11(2):72–80. [PMC free article] [PubMed] [Google Scholar]
  • 19.Luan X., Zhou X., Trombetta-eSilva J. MicroRNAs and periodontal homeostasis. Journal of Dental Research . 2017;96(5):491–500. doi: 10.1177/0022034516685711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fouad A. F., Khan A. A., Silva R. M. Genetic and epigenetic characterization of pulpal and periapical inflammation. Frontiers in Physiology . 2020;11:p. 21. doi: 10.3389/fphys.2020.00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang H., Feng C., Wang M., Yang S., Wei F. Circular RNAs: diversity of functions and a regulatory nova in oral medicine: a pilot review. Cell Transplantation . 2019 Jul;28(7):819–830. doi: 10.1177/0963689719837917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Naqvi A. R., Shango J., Seal A. Herpesviruses and MicroRNAs: new pathogenesis factors in oral infection and disease? Frontiers in Immunology . 2018;27(9):p. 2099. doi: 10.3389/fimmu.2018.02099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yuan Y., Zhang H., Huang H. microRNAs in inflammatory alveolar bone defect: a review. Journal of Periodontal Research . 2021;56(2):219–225. doi: 10.1111/jre.12819. [DOI] [PubMed] [Google Scholar]
  • 24.Adeodato C. S. R., Alves G. G., Botelho A. M. N., et al. Association of DNA sequence-independent genetic regulatory mechanisms with apical periodontitis: a scoping review. Archives of Oral Biology . 2020;115 doi: 10.1016/j.archoralbio.2020.104737.104737 [DOI] [PubMed] [Google Scholar]
  • 25.Kulkarni V., Uttamani J. R., Naqvi A. R., Nares S. microRNAs: emerging players in oral cancers and inflammatory disorders. Tumour Biol . 2017;39(5) doi: 10.1177/1010428317698379.101042831769837 [DOI] [PubMed] [Google Scholar]
  • 26.Sanz M., Marco Del Castillo A., Jepsen S. Periodontitis and cardiovascular diseases: consensus report. Journal of Clinical Periodontology . 2020;47(3):268–288. doi: 10.1111/jcpe.13189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bartold P. M. Lifestyle and periodontitis: the emergence of personalized periodontics. Periodontology . 2018;78(1):7–11. doi: 10.1111/prd.12237. [DOI] [PubMed] [Google Scholar]
  • 28.Kinney J. S., Ramseier C. A., Giannobile W. V. Oral fluid–based biomarkers of alveolar bone loss in periodontitis. Annals of the New York Academy of Sciences . 2007;1098(1):230–251. doi: 10.1196/annals.1384.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.He W., You M., Wan W., Xu F., Li F., Li A. Point-of-care periodontitis testing: biomarkers, current technologies, and perspectives. Trends in Biotechnology . 2018;36(11):1127–1144. doi: 10.1016/j.tibtech.2018.05.013. [DOI] [PubMed] [Google Scholar]
  • 30.Jiang M., Zhang C., Cao H., Chan K., Lu A. The role of Chinese medicine in the treatment of chronic diseases in China. Planta Medica . 2011;77(09):873–881. doi: 10.1055/s-0030-1270983. [DOI] [PubMed] [Google Scholar]
  • 31.Watanabe S., Toyama T., Sato T., et al. Kampo therapies and the use of herbal medicines in the dentistry in Japan. Medicines . 2019;6(1):p. 34. doi: 10.3390/medicines6010034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cao C. F., Sun X. P. Herbal medicine for periodontal diseases. International Dental Journal . 1998;48(S3):316–321. doi: 10.1111/j.1875-595x.1998.tb00722.x. [DOI] [PubMed] [Google Scholar]
  • 33.Flaws B. The treatment of periodontal disease with Chinese medicine. Townsend Letter for Doctors and Patients . 2005 Jun;1(263):29–32. [Google Scholar]
  • 34.Breivik T., Thrane P. S., Murison R., Gjermo P. Emotional stress effects on immunity, gingivitis and periodontitis. European Journal of Oral Sciences . 1996;104(4):327–334. doi: 10.1111/j.1600-0722.1996.tb00087.x. [DOI] [PubMed] [Google Scholar]
  • 35.Gurav A. N. Management of diabolical diabetes mellitus and periodontitis nexus: are we doing enough? World Journal of Diabetes . 2016;7(4):p. 50. doi: 10.4239/wjd.v7.i4.50. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES